Filing Details
- Accession Number:
- 0000899243-22-034883
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-03 16:05:18
- Reporting Period:
- 2022-11-01
- Accepted Time:
- 2022-11-03 16:05:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-01 | 768 | $312.84 | 38,424 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-11-02 | 56 | $310.10 | 38,368 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 39 | $311.17 | 38,329 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 100 | $312.40 | 38,229 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 81 | $313.37 | 38,148 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 12 | $314.43 | 38,136 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 10 | $315.68 | 38,126 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-02 | 22 | $317.77 | 38,104 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
- Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $310.10 (range $309.50 to $310.48).
- Open market sales reported on this line occurred at a weighted average price of $311.17 (range $310.51 to $311.45).
- Open market sales reported on this line occurred at a weighted average price of $312.40 (range $311.98 to $312.90).
- Open market sales reported on this line occurred at a weighted average price of $313.37 (range $312.98 to $313.97).
- Open market sales reported on this line occurred at a weighted average price of $314.43 (range $314.42 to $314.48).
- Open market sales reported on this line occurred at a weighted average price of $317.77 (range $317.56 to $317.82).
Billionaire Hedge Funds
